share_log

424B5: Prospectus

424B5: Prospectus

424B5：募資說明書
美股SEC公告 ·  07/11 09:03
Moomoo AI 已提取核心訊息
SeaStar Medical Holding Corporation, a medical technology company, has announced a registered direct offering of 947,868 shares of its common stock at a price of $10.55 per share. The offering is accompanied by a concurrent private placement of unregistered common stock purchase warrants, exercisable at $10.55, immediately upon issuance and expiring five years from the date of issuance. The purchase price for each share of common stock is also set at $10.55. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close on or about July 11, 2024, subject to customary closing conditions. The proceeds, before expenses, are estimated to be approximately $9.3 million and are intended for the redemption and repayment of certain notes, as well as funding the company's development and commercialization activities and general corporate purposes. This offering follows SeaStar Medical's recent compliance with Nasdaq's minimum market value requirement and its ongoing efforts to maintain its listing on the exchange.
SeaStar Medical Holding Corporation, a medical technology company, has announced a registered direct offering of 947,868 shares of its common stock at a price of $10.55 per share. The offering is accompanied by a concurrent private placement of unregistered common stock purchase warrants, exercisable at $10.55, immediately upon issuance and expiring five years from the date of issuance. The purchase price for each share of common stock is also set at $10.55. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close on or about July 11, 2024, subject to customary closing conditions. The proceeds, before expenses, are estimated to be approximately $9.3 million and are intended for the redemption and repayment of certain notes, as well as funding the company's development and commercialization activities and general corporate purposes. This offering follows SeaStar Medical's recent compliance with Nasdaq's minimum market value requirement and its ongoing efforts to maintain its listing on the exchange.
醫療科技公司SeaStar Medical Holding Corporation宣佈以每股10.55美元的價格註冊了947,868股普通股的直接發售。該發售將伴隨着未經註冊的普通股認購權的定向增發，認購價格爲10.55美元，即發行後立即行使，到期日爲發行日起五年。普通股的購買價格也定爲10.55美元。H.C. Wainwright & Co.擔任發售的獨家代理，預計將於2024年7月11日左右關閉，須符合慣例的結算條件。在扣除費用前，所得款項約爲930萬美元，並擬用於贖回和償還某些票據，以及資助公司的開發和商業化活動以及一般企業用途。本次發售是SeaStar Medical遵循納斯達克最低市值要求和維持在該交易所上市的不斷努力之後進行的。
醫療科技公司SeaStar Medical Holding Corporation宣佈以每股10.55美元的價格註冊了947,868股普通股的直接發售。該發售將伴隨着未經註冊的普通股認購權的定向增發，認購價格爲10.55美元，即發行後立即行使，到期日爲發行日起五年。普通股的購買價格也定爲10.55美元。H.C. Wainwright & Co.擔任發售的獨家代理，預計將於2024年7月11日左右關閉，須符合慣例的結算條件。在扣除費用前，所得款項約爲930萬美元，並擬用於贖回和償還某些票據，以及資助公司的開發和商業化活動以及一般企業用途。本次發售是SeaStar Medical遵循納斯達克最低市值要求和維持在該交易所上市的不斷努力之後進行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息